Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity NEW YORK (March 2, 2026)—TB
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity NEW YORK (March 2, 2026)—TB
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of thousands worldwide NEW YORK (January
Partnership will support the development of investigational drug telacebec for the treatment of tuberculosis, leprosy, and Buruli ulcer NEW YORK
New York, USA and Manila, Philippines — [Date] — TB Alliance and the Asian Development Bank (ADB) have announced a
For many children, and plenty of adults, swallowing tablets is hard. Ready-made syrups are often unavailable, poorly palatable, or impractical
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark
Thuto Pulane, a TB survivor and participant in the NC-009 trial, at a follow-up appointment with Dr. William Brumskine, NC-009
TB Alliance is gratified to see clear progress against tuberculosis in the latest WHO Global TB Control Report. While TB
For decades, breakthrough TB science has too often moved slowly from approval to those in need. In the roll out
Digital Training Platform, Upskill TB, Strengthens Capacity to Deliver New DR-TB Treatments JAKARTA (October 9, 2025)—TB Alliance, in collaboration with